ID   MBB1A_HUMAN             Reviewed;        1328 AA.
AC   Q9BQG0; Q86VM3; Q9BW49; Q9P0V5; Q9UF99;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2005, sequence version 2.
DT   12-APR-2017, entry version 146.
DE   RecName: Full=Myb-binding protein 1A;
GN   Name=MYBBP1A; Synonyms=P160;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=10644447; DOI=10.1006/geno.1999.6035;
RA   Keough R., Woollatt E., Crawford J., Sutherland G.R., Plummer S.,
RA   Casey G., Gonda T.J.;
RT   "Molecular cloning and chromosomal mapping of the human homologue of
RT   MYB binding protein (P160) 1A (MYBBP1A) to 17p13.3.";
RL   Genomics 62:483-489(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 82-1328 (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 875-1328 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.E02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-775, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION IN THE B-WICH COMPLEX.
RX   PubMed=16603771; DOI=10.1074/jbc.M600233200;
RA   Cavellan E., Asp P., Percipalle P., Oestlund Farrants A.-K.;
RT   "The WSTF-SNF2h chromatin remodeling complex interacts with several
RT   nuclear proteins in transcription.";
RL   J. Biol. Chem. 281:16264-16271(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND SER-1163, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1186, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775 AND
RP   SER-1290, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775; SER-1159;
RP   SER-1163; SER-1186; THR-1190; THR-1196; SER-1207; SER-1248; SER-1267;
RP   SER-1303; SER-1308 AND SER-1314, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775 AND SER-1267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71 AND LYS-158, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775; SER-1163;
RP   SER-1267; SER-1290; SER-1308; SER-1310 AND SER-1314, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775; SER-1163; SER-1232;
RP   SER-1267; THR-1269 AND SER-1290, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-1159; SER-1163;
RP   SER-1186; THR-1239; SER-1241; SER-1248; SER-1267; SER-1290; SER-1308;
RP   SER-1310 AND SER-1314, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: May activate or repress transcription via interactions
CC       with sequence specific DNA-binding proteins. Repression may be
CC       mediated at least in part by histone deacetylase activity (HDAC
CC       activity). Acts as a corepressor and in concert with CRY1,
CC       represses the transcription of the core circadian clock component
CC       PER2. Preferentially binds to dimethylated histone H3 'Lys-9'
CC       (H3K9me2) on the PER2 promoter. {ECO:0000250|UniProtKB:Q7TPV4}.
CC   -!- SUBUNIT: Binds to and represses JUN and MYB via the leucine zipper
CC       regions present in these proteins. Also binds to and represses
CC       PPARGC1A: this interaction is abrogated when PPARGC1A is
CC       phosphorylated by MAPK1/ERK. Binds to and stimulates transcription
CC       by AHR. Binds to KPNA2. Interacts with CLOCK and CRY1 (By
CC       similarity). Component of the B-WICH complex, at least composed of
CC       SMARCA5/SNF2H, BAZ1B/WSTF, SF3B1, DEK, MYO1C, ERCC6, MYBBP1A and
CC       DDX21. {ECO:0000250|UniProtKB:Q7TPV4,
CC       ECO:0000269|PubMed:16603771}.
CC   -!- INTERACTION:
CC       Q7L2E3:DHX30; NbExp=3; IntAct=EBI-676973, EBI-1211456;
CC       Q9Y5X4:NR2E3; NbExp=2; IntAct=EBI-676973, EBI-7216962;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12429849}.
CC       Nucleus {ECO:0000269|PubMed:12429849}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:12429849}. Note=Shuttles between the nucleus
CC       and cytoplasm. Nuclear import may be mediated by KPNA2, while
CC       export appears to depend partially on XPO1/CRM1 (By similarity).
CC       Predominantly nucleolar. {ECO:0000250|UniProtKB:Q7TPV4}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BQG0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BQG0-2; Sequence=VSP_014786;
CC         Note=May be due to competing donor and acceptor splice sites.;
CC   -!- PTM: Citrullinated by PADI4. {ECO:0000250|UniProtKB:Q7TPV4}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB66530.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYBBP1AID41467ch17p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF147709; AAF33021.1; -; mRNA.
DR   EMBL; BC000641; AAH00641.2; -; mRNA.
DR   EMBL; BC050546; AAH50546.1; -; mRNA.
DR   EMBL; AL136595; CAB66530.1; ALT_INIT; mRNA.
DR   EMBL; AL133098; CAB61409.1; -; mRNA.
DR   CCDS; CCDS11046.1; -. [Q9BQG0-1]
DR   CCDS; CCDS42238.1; -. [Q9BQG0-2]
DR   PIR; T42680; T42680.
DR   RefSeq; NP_001099008.1; NM_001105538.1. [Q9BQG0-2]
DR   RefSeq; NP_055335.2; NM_014520.3. [Q9BQG0-1]
DR   UniGene; Hs.22824; -.
DR   UniGene; Hs.701718; -.
DR   ProteinModelPortal; Q9BQG0; -.
DR   BioGrid; 115770; 121.
DR   IntAct; Q9BQG0; 44.
DR   MINT; MINT-1150245; -.
DR   STRING; 9606.ENSP00000370968; -.
DR   iPTMnet; Q9BQG0; -.
DR   PhosphoSitePlus; Q9BQG0; -.
DR   SwissPalm; Q9BQG0; -.
DR   BioMuta; MYBBP1A; -.
DR   DMDM; 71153825; -.
DR   SWISS-2DPAGE; Q9BQG0; -.
DR   EPD; Q9BQG0; -.
DR   MaxQB; Q9BQG0; -.
DR   PaxDb; Q9BQG0; -.
DR   PeptideAtlas; Q9BQG0; -.
DR   PRIDE; Q9BQG0; -.
DR   DNASU; 10514; -.
DR   Ensembl; ENST00000254718; ENSP00000254718; ENSG00000132382. [Q9BQG0-1]
DR   Ensembl; ENST00000381556; ENSP00000370968; ENSG00000132382. [Q9BQG0-2]
DR   GeneID; 10514; -.
DR   KEGG; hsa:10514; -.
DR   UCSC; uc002fxz.5; human. [Q9BQG0-1]
DR   CTD; 10514; -.
DR   DisGeNET; 10514; -.
DR   GeneCards; MYBBP1A; -.
DR   H-InvDB; HIX0013445; -.
DR   HGNC; HGNC:7546; MYBBP1A.
DR   HPA; HPA005466; -.
DR   MIM; 604885; gene.
DR   neXtProt; NX_Q9BQG0; -.
DR   OpenTargets; ENSG00000132382; -.
DR   PharmGKB; PA31346; -.
DR   eggNOG; KOG1926; Eukaryota.
DR   eggNOG; ENOG410YFVF; LUCA.
DR   GeneTree; ENSGT00390000017457; -.
DR   HOGENOM; HOG000113488; -.
DR   HOVERGEN; HBG081961; -.
DR   InParanoid; Q9BQG0; -.
DR   KO; K02331; -.
DR   OMA; EDKFPRF; -.
DR   OrthoDB; EOG091G00YE; -.
DR   PhylomeDB; Q9BQG0; -.
DR   TreeFam; TF317401; -.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   SIGNOR; Q9BQG0; -.
DR   ChiTaRS; MYBBP1A; human.
DR   GeneWiki; MYBBP1A; -.
DR   GenomeRNAi; 10514; -.
DR   PMAP-CutDB; Q9BQG0; -.
DR   PRO; PR:Q9BQG0; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000132382; -.
DR   CleanEx; HS_MYBBP1A; -.
DR   ExpressionAtlas; Q9BQG0; baseline and differential.
DR   Genevisible; Q9BQG0; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0042564; C:NLS-dependent protein nuclear import complex; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001047; F:core promoter binding; ISS:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; TAS:ProtInc.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; ISS:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:2000210; P:positive regulation of anoikis; IMP:CACAO.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; IMP:UniProtKB.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0022904; P:respiratory electron transport chain; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.10.10; -; 2.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR007015; DNA_pol_V.
DR   PANTHER; PTHR13213; PTHR13213; 1.
DR   Pfam; PF04931; DNA_pol_phi; 1.
DR   SUPFAM; SSF48371; SSF48371; 5.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Biological rhythms;
KW   Citrullination; Complete proteome; Cytoplasm; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   1328       Myb-binding protein 1A.
FT                                /FTId=PRO_0000096255.
FT   REGION        1    582       Interaction with MYB.
FT                                {ECO:0000250|UniProtKB:Q7TPV4}.
FT   REGION     1151   1328       Required for nuclear and nucleolar
FT                                localization.
FT                                {ECO:0000250|UniProtKB:Q7TPV4}.
FT   MOTIF       240    258       Nuclear export signal 1.
FT                                {ECO:0000250|UniProtKB:Q7TPV4}.
FT   MOTIF       263    281       Nuclear export signal 2.
FT                                {ECO:0000250|UniProtKB:Q7TPV4}.
FT   COMPBIAS    720    784       Glu-rich.
FT   MOD_RES      11     11       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      71     71       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     158    158       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     775    775       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1159   1159       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1163   1163       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1186   1186       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1190   1190       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1196   1196       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1207   1207       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1232   1232       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1239   1239       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1241   1241       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1244   1244       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q7TPV4}.
FT   MOD_RES    1248   1248       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1267   1267       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1269   1269       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES    1290   1290       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1303   1303       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1307   1307       Citrulline.
FT                                {ECO:0000250|UniProtKB:Q7TPV4}.
FT   MOD_RES    1308   1308       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1310   1310       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1314   1314       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ    1322   1328       VRKAGKP -> TLRFTISSSKK (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_014786.
FT   VARIANT       8      8       Q -> E (in dbSNP:rs3809849).
FT                                /FTId=VAR_023064.
FT   VARIANT     680    680       H -> Y (in dbSNP:rs899440).
FT                                /FTId=VAR_051156.
FT   VARIANT     958    958       H -> P (in dbSNP:rs879797).
FT                                /FTId=VAR_051157.
FT   VARIANT    1208   1208       M -> L (in dbSNP:rs9905742).
FT                                /FTId=VAR_051158.
FT   CONFLICT    307    307       R -> H (in Ref. 1; AAF33021).
FT                                {ECO:0000305}.
FT   CONFLICT    570    570       R -> H (in Ref. 1; AAF33021).
FT                                {ECO:0000305}.
FT   CONFLICT    601    601       L -> F (in Ref. 1; AAF33021).
FT                                {ECO:0000305}.
FT   CONFLICT   1028   1028       H -> R (in Ref. 2; AAH50546).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1328 AA;  148855 MW;  0B053465D5B3511F CRC64;
     MESRDPAQPM SPGEATQSGA RPADRYGLLK HSREFLDFFW DIAKPEQETR LAATEKLLEY
     LRGRPKGSEM KYALKRLITG LGVGRETARP CYSLALAQLL QSFEDLPLCS ILQQIQEKYD
     LHQVKKAMLR PALFANLFGV LALFQSGRLV KDQEALMKSV KLLQALAQYQ NHLQEQPRKA
     LVDILSEVSK ATLQEILPEV LKADLNIILS SPEQLELFLL AQQKVPSKLK KLVGSVNLFS
     DENVPRLVNV LKMAASSVKK DRKLPAIALD LLRLALKEDK FPRFWKEVVE QGLLKMQFWP
     ASYLCFRLLG AALPLLTKEQ LHLVMQGDVI RHYGEHVCTA KLPKQFKFAP EMDDYVGTFL
     EGCQDDPERQ LAVLVAFSSV TNQGLPVTPT FWRVVRFLSP PALQGYVAWL RAMFLQPDLD
     SLVDFSTNNQ KKAQDSSLHM PERAVFRLRK WIIFRLVSIV DSLHLEMEEA LTEQVARFCL
     FHSFFVTKKP TSQIPETKHP FSFPLENQAR EAVSSAFFSL LQTLSTQFKQ APGQTQGGQP
     WTYHLVQFAD LLLNHSHNVT TVTPFTAQQR QAWDRMLQTL KELEAHSAEA RAAAFQHLLL
     LVGIHLLKSP AESCDLLGDI QTCIRKSLGE KPRRSRTKTI DPQEPPWVEV LVEILLALLA
     QPSHLMRQVA RSVFGHICSH LTPRALQLIL DVLNPETSED ENDRVVVTDD SDERRLKGAE
     DKSEEGEDNR SSESEEESEG EESEEEERDG DVDQGFREQL MTVLQAGKAL GGEDSENEEE
     LGDEAMMALD QSLASLFAEQ KLRIQARRDE KNKLQKEKAL RRDFQIRVLD LVEVLVTKQP
     ENALVLELLE PLLSIIRRSL RSSSSKQEQD LLHKTARIFT HHLCRARRYC HDLGERAGAL
     HAQVERLVQQ AGRQPDSPTA LYHFNASLYL LRVLKGNTAE GCVHETQEKQ KAGTDPSHMP
     TGPQAASCLD LNLVTRVYST ALSSFLTKRN SPLTVPMFLS LFSRHPVLCQ SLLPILVQHI
     TGPVRPRHQA CLLLQKTLSM REVRSCFEDP EWKQLMGQVL AKVTENLRVL GEAQTKAQHQ
     QALSSLELLN VLFRTCKHEK LTLDLTVLLG VLQGQQQSLQ QGAHSTGSSR LHDLYWQAMK
     TLGVQRPKLE KKDAKEIPSA TQSPISKKRK KKGFLPETKK RKKRKSEDGT PAEDGTPAAT
     GGSQPPSMGR KKRNRTKAKV PAQANGTPTT KSPAPGAPTR SPSTPAKSPK LQKKNQKPSQ
     VNGAPGSPTE PAGQKQHQKA LPKKGVLGKS PLSALARKKA RLSLVIRSPS LLQSGAKKKA
     QVRKAGKP
//
